查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449633

全球霍乱疫苗市场：按产品类型、按疫苗类型、按患者类型、按分销管道、按地区

Global Cholera Vaccines Market, By Product Type, By Vaccine Type, By Patient Type, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球霍乱疫苗市场预计2023年将达到8,250万美元，2031年将达到2.046亿美元，2024年至2031年复合年增长率为12%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 8250万美元
实际资料 2019-2023 预测期 2024-2031
预测期间 2023/2024 至 2030/2031 年复合年增长率： 12.00% 2030/2031 年预测值 2.046 亿美元
图 1. 2023 年霍乱疫苗全球市场占有率（按地区划分）
全球霍乱疫苗市场-IMG1

霍乱是一种细菌性疾病，通常透过受污染的水传播。它会导致严重腹泻和脱水，如果不及时治疗，可能会在几小时内导致死亡。这种疾病在水处理不足、环境卫生和卫生条件不佳的地区最为流行，例如非洲、东南亚和海地。世界卫生组织（WHO）和联合国儿童基金会（UNICEF）警告说，霍乱正在捲土重来，特别是针对弱势社区。当贫穷、战争或自然灾害迫使人们生活在拥挤且缺乏足够卫生设施的环境中时，霍乱爆发的风险最大。霍乱是一种贫困疾病，影响着无法获得安全用水和基本卫生设施的人。霍乱不会直接在人与人之间传播，因此与感染者的偶然接触并不是患上这种疾病的主要危险因子。从预防的角度来看，采取多方面的方法对于控制霍乱和减少死亡非常重要。这包括获得安全用水、适当的环境卫生和个人卫生以及在高风险地区接种疫苗。

市场动态：

推动全球霍乱疫苗市场成长的主要因素包括全球霍乱疾病负担的增加、人们对预防霍乱疫情的兴趣日益浓厚以及保护时间更长的新型口服疫苗的市场开拓。但低收入地区疫苗可近性不足、部分地区疫苗接种意识不高等因素持续在一定程度上限制市场潜力。从乐观的角度来看，增加对寻找针对多种血清型提供交叉保护的疫苗的投资正在开闢新的途径。製造商和国际组织之间为提高流行地区的可用性而建立的伙伴关係也将是未来几年的一个有吸引力的机会。

本研究的主要特点

  • 本报告对全球霍乱疫苗市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 该报告根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球霍乱疫苗市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 霍乱疫苗全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球霍乱疫苗市场的各种策略矩阵，促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 加强疫苗接种宣传活动
    • 霍乱疫苗供不应求
    • 增加教育培训项目
  • 主要亮点
  • 监管场景
  • 市场趋势
  • 管道分析
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 流行病学
  • 治疗流程（病人历程）
  • 治疗方案分析
  • 主要市场参与者的新投资
  • 价格分析
  • 疾病意识计划
  • 治疗安全性和有效性分析
  • 合併、收购和合作

第四章全球霍乱疫苗市场 - 冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球霍乱疫苗市场，依产品类型，2019-2031

  • Vaxchora
  • Dukoral
  • ShanChol
  • Euvichol-Plus/Euvichol
  • 其他（后期疫苗等）

第六章全球霍乱疫苗市场，依疫苗类型，2019-2031

  • 灭活全细胞疫苗和重组霍乱毒素B疫苗
  • 仅含有杀死的全细胞的疫苗
  • 口服霍乱减毒活活病毒疫苗

第七章全球霍乱疫苗市场，依病患类型，2019-2031

  • 儿童
  • 成人

第8章全球霍乱疫苗市场，依通路，2019-2031

  • 公共
  • 私人的

第九章全球霍乱疫苗市场，按地区，2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争格局

  • 公司简介
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd（Hillhouse Capital）
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.

第11章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6646

The global cholera vaccines market was valued US$ 82.5 Mn in 2023 and is expected to reach US$ 204.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 12% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 82.5 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 12.00% 2030/2031 Value Projection: US$ 204.6 Mn
Figure 1. Global Cholera Vaccines Market Share (%), By Region, 2023
Global Cholera Vaccines Market - IMG1

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.

Market Dynamics:

Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.

Key features of the study:

  • This report provides in-depth analysis of the global cholera vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market

Detailed Segmentation:

  • Global Cholera Vaccines Market, By Product Type
    • Vaxchora
    • Dukoral
    • ShanChol
    • Euvichol-Plus/Euvichol
    • Others (Late Phase Vaccines, etc.)
  • Global Cholera Vaccines Market, By Vaccine Type
    • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Killed Whole-cell Only Vaccines
    • Live Attenuated Oral Cholera Vaccine
  • Global Cholera Vaccines Market, By Patient Type
    • Pediatric
    • Adults
  • Global Cholera Vaccines Market, By Distribution Channel
    • Public
    • Private
  • Global Cholera Vaccines Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in the Global Cholera Vaccines Market:
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing Vaccination Campaigns
    • Supply Shortage of Cholera Vaccine
    • Increasing Educational Training Programmes
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Pipeline Analysis
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • Treatment Algorithm (Patient Journey)
  • Treatment Option Analysis
  • New Investments by Major Market Players
  • Pricing Analysis
  • Disease Awareness Programs
  • Treatment Safety and Efficacy Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Cholera Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cholera Vaccines Market, By Product Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Vaxchora
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Dukoral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • ShanChol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Euvichol-Plus/Euvichol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others (Late Phase Vaccines, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Cholera Vaccines Market, By Vaccine Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Killed Whole-cell Only Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Live Attenuated Oral Cholera Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Cholera Vaccines Market, By Patient Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Cholera Vaccines Market, By Distribution Channel, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 201s9-2031,(US$ Mn)

9. Global Cholera Vaccines Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • Sanofi
    • Biovac.co.za.
    • EMERGENT
    • Celldex Therapeutics
    • Valneva SE
    • Hilleman Laboratories
    • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
    • PaxVax, Inc.
    • Astellas Pharma Inc.
    • EUBIOLOGICS CO., LTD.
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us